What is it about?
Tumors can contain bacteria as well as cancer and immune cells, but we are only beginning to understand how these microbes influence local immunity. We studied MAIT cells, a specialized type of immune cell that recognizes small vitamin B2–related molecules displayed by a protein called MR1. We found that select Enterococcus species did not activate MAIT cells directly. Instead, they increased the amount of MR1 displayed on the surface of antigen-presenting cells when an activating metabolite was available. This enhanced MAIT-cell activation appears to involve changes in the intracellular processing and transport of MR1 rather than increased production of MR1 itself. Our findings reveal a previously unrecognized way in which bacteria within tumors may shape immune recognition
Featured Image
Photo by National Institute of Allergy and Infectious Diseases on Unsplash
Why is it important?
Cancer research often focuses on whether tumor-associated bacteria produce molecules that activate or suppress immune cells. Our study shows that bacteria may also influence immunity by changing how effectively host cells display those molecules to the immune system. This mechanism connects the tumor microbiome with the MR1–MAIT immune pathway and provides a framework for investigating how microbes affect immune surveillance within tumors. It may also help guide future MR1-based immunotherapies. However, the study does not yet establish whether Enterococcus, MR1 expression, or MAIT-cell activation improves treatment response or patient outcomes; these questions require further clinical and experimental investigation
Perspectives
This study changes how we may think about bacteria living inside tumors. Rather than simply producing substances that activate immune cells, some bacteria may act more like “signal amplifiers.” Select Enterococcus species appear to help antigen-presenting cells move more MR1 molecules to their surface, making an existing vitamin B2–related signal more visible to MAIT immune cells. The findings raise the possibility that the tumor microbiome influences not only which immune signals are present, but also how effectively those signals are displayed. Future research should determine whether this mechanism occurs in patients, whether it affects responses to immunotherapy, and whether it can be safely harnessed in MR1- or MAIT-cell-based cancer treatments. The present study identifies a promising biological mechanism, but it does not show that Enterococcus improves treatment outcomes
Franck Housseau
INSERM U1366
Read the Original
This page is a summary of: Select intratumoral riboflavin-auxotrophic
Enterococcus
species enhance cell surface MR1 expression and MAIT TCR activation in lung cancer, Proceedings of the National Academy of Sciences, August 2026, Proceedings of the National Academy of Sciences,
DOI: 10.1073/pnas.2617943123.
You can read the full text:
Contributors
The following have contributed to this page
